The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Potapova K.V.

Privolzhsky Research Medical University of the Ministry of Health of Russia, Nizhny Novgorod, Russia

Nosov V.P.

Nizhny Novgorod State Medical Academy of Healthcare Ministry of the Russia Nizhny Novgorod, Russia

Koroleva L.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Amineva N.V.

Privolzhsky Research Medical University of the Ministry of Health of Russia, Nizhny Novgorod, Russia

Modern aspects of the management of atrial flutter

Authors:

Potapova K.V., Nosov V.P., Koroleva L.Yu., Amineva N.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(2): 127‑133

DOI: 10.17116/kardio202013021127

Read: 18770 times

Download PDF (RU)
Contact the author
Table of contents

MODERN ASPECTS OF THE MANAGEMENT OF ATRIAL FLUTTER
MODERN ASPECTS OF THE MANAGEMENT OF ATRIAL FLUTTER

To cite this article:

Potapova KV, Nosov VP, Koroleva LYu, Amineva NV. Modern aspects of the management of atrial flutter. Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(2):127‑133. (In Russ.)
https://doi.org/10.17116/kardio202013021127

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Correction of postoperative meta­bolic diso­rders after radiofrequency abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):680-684
Thoracoscopic rese­ction of giant left atrial appe­ndage aneurysm with epicardial radiofrequency isolation of pulmonary veins and posterior wall of the left atrium without cardiopulmonary bypass. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):713-718
Phase II clinical trial of refralon tablets in patients with persistent atrial fibrillation and atrial flutter. The stru­cture and plan of the study. Russian Cardiology Bulletin. 2024;(4-2):182-187
Refralon for drug-induced cardioversion of atrial fibrillation in patients with coro­nary artery disease. Russian Cardiology Bulletin. 2024;(4-2):188-196
Influence of local anesthesia methods on the resu­lts of radiofrequency facet dene­rvation. Burdenko's Journal of Neurosurgery. 2025;(2):57-61
The CryoMaze procedure for non-paroxysmal atrial fibrillation in patients unde­rgoing heart valve surgery. Piro­gov Russian Journal of Surgery. 2025;(5):65-71
Pote­ntial for the six-minute walk test use in patients with atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(10):129-133
Groin Soft Tissue Leiomyosarcoma or Femo­ral Vein Leiomyosarcoma?. Journal of Venous Diso­rders. 2025;(4):316-319
Abstract:

Atrial flutter (AFl) may be completely cured in most cases due to the achievements of interventional surgery (up to 100% after repeated interventions). However, post-ablation atrial fibrillation (AF) is a significant problem causing fatal and non-fatal embolic cardiac complications. Incidence of post-ablation AF directly correlates with left atrial dimension. It is confirmed that AFl results progressive structural, functional and electrophysiological changes in all cardiac chambers regardless clinical course, contributes to chronic arrhythmia and facilitates subsequent development of post-ablation AF. Sinus rhythm control for any type of AFl is needed to maintain normal cardiac dimensions. It is essential for complete correction of arrhythmias and prevention of post-ablation AF.

Keywords:

atrial flutter
post-ablation atrial fibrillation
drug cardioversion
electrical cardioversion
radiofrequency ablation

Authors:

Potapova K.V.

Privolzhsky Research Medical University of the Ministry of Health of Russia, Nizhny Novgorod, Russia

Nosov V.P.

Nizhny Novgorod State Medical Academy of Healthcare Ministry of the Russia Nizhny Novgorod, Russia

Koroleva L.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Amineva N.V.

Privolzhsky Research Medical University of the Ministry of Health of Russia, Nizhny Novgorod, Russia

Close metadata

References:

  1. Cemin R, Manfrin M, Daves M, Rauhe W, Maggioni AP. Ten years differences in recently onset atrial fibrillation and flutter incidence and management. 2014;82:153-159. 
  2. Zipes DP, Jalife J, Stevenson WG.  7th Edition. Philadelphia: Elsevier; 2018.
  3. Rahman F, Wang N, Yin X, Ellinor PT, Lubitz SA, LeLorier PA, et al. Atrial flutter: clinical risk factors and adverse outcomes in the Framingham Heart Study. . 2016;13:233-240. 
  4. Zipes D, Libby P, Bonow R, Mann D, Tomaselli G.  2-Volume Set 11th Edition. Philadelphia: Elsevier; 2019.
  5. Manolis AS. Contemporary diagnosis and management of atrial flutter: a continuum of atrial fibrillation and vice versa? 2017 Nov-Dec;25(6):289-297. 
  6. Kushakovsky MS, Grishkin YuN.  4-e izd., ispr. i dop. SPb: Foliant; 2014. (In Russ.)
  7. Josephson ME.  5th Edition. Boston: Wolters Kluwer; 2016.
  8. Aguilar M, Nattel S. The pioneering work of George Mines on cardiac arrhythmias: groundbreaking ideas that remain influential in contemporary cardiac electrophysiology. . 2016 May 01;594(9):2377-2386.
  9. Ardashev AV.  M.: Medpraktika-M; 2012. (In Russ.)
  10. Cabrera JA, Sanchez-Quintana D, Farre G, et al. The inferior right atrial isthmus: further architectural insights for current and coming ablation technologies. 2005;16:402-408. 
  11. Chaplygina EV, Chudinov GV, Kornienko NA. Structural peculiarities in electroanatomi right atrium mapping. 2012;2:50-54. (In Russ.)
  12. Saoudi N, Cosio F, Waldo A, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 2001;12:852-866. 
  13. Giehm-Reese M, Lukac P, Kristiansen SB, et al. Outcome after catheter ablation for left atrial flutter. 2019 June;53(3):133-140. 
  14. Gula LJ, Redfearn DP, Jenkyn KB, et al. Elevated incidence of atrial fibrillation and stroke in patients with atrial flutter-a population-based study. 2018 June;34(6):774-783. 
  15. Al-Kawaz M, Omran SS, Parikh NS, et al. Comparative risks of ischemic stroke in atrial flutter versus atrial fibrillation. 2018 Apr;27(4):839-844. 
  16. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 2019 Jan 28. pii: S1547-5271(19)30037-2. 
  17. Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: Insights from the ARISTOTLE trial. . 2014;63(11):1082-1087.
  18. Monteiro JMC, San-Martin DL, Silva BCG, et al. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. 2019 Feb;77(2):80-83. 
  19. Lehrmann H, Weber R, Park CI, Allgeier J, Schiebeling-Romer J, Arentz T, et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. 2012;9:1942-1946.
  20. Jin MN, Song C, Kim TH, et al. CHA₂DS₂-VASc score in the prediction of ischemic stroke in patients after radiofrequency catheter ablation of typical atrial flutter. 2018 Mar; 59(2):236-242. 
  21. Scheuermeyer FX, Pourvali R, Rowe BH, et al. Emergency department patients with atrial fibrillation or flutter and an acute underlying medical illness may not benefit from attempts to control rate or rhythm. 2015 May;65(5):511-522. 
  22. Fromm C, Suau SJ, Cohen V, et al. Diltiazem vs. Metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department. 2015;49(2):175-182. 
  23. Vserossijskoe nauchnoe obshchestvo spetsialistov po klinicheskoj elektrofiziologii, aritmologii i kardiostimulyatsii (VNOA). Moscow; 2017:702. (In Russ.)
  24. Frommeyer G, Brachmann J, Ince H, et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. 2019 Feb 23. 
  25. Vinson DR, Lugovskaya N, Warton EM, et al. Ibutilide effectiveness and safety in the cardioversion of atrial fibrillation and flutter in the community emergency department. 2018 Jan;71(1):96-108. 
  26. Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? 2019 Jan;24(1):3-10. 
  27. Abraham JM, Saliba WI, Vekstein C, et al. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter. 2015 Aug;8(4):772-776. 
  28. Hamilton A, Clark D, Gray A, et al. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. 2015 June;22(3):155-161. 
  29. Maykov EB, Yuricheva YuA, Mironov NYu, Sokolov SF, Golitsyn SP, Rozenshtraukh LV, Chazov EI. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. . 2015;87(1):38-48. (In Russ.)
  30. Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. 2016 Jan-Mar;6(1):8-16. 
  31. Naccarelli GV, Kowey PR. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. 2014 Nov;10(4):303-308. 
  32. Sokolov SF, Bomonina EV. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. 2015;3(6):65-75. (In Russ.)
  33. Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review. 2014 July;21(7):717-726. 
  34. Grönberg T, Nuotio I, Nikkinen M. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. 2013 Oct;15(10):1432-1435.
  35. Sulimov VA, Dubrovsky IA, Kanorsky SG, et al.  2-e izdanie. GEOTAR-Media; 2015. (In Russ.)
  36. Olesin AI, Smolin ZYu, Konovalova OA, Shabrov AV. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. . 2009;9:37-41. (In Russ.)
  37. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). 2020 Feb 1;41(5):655-720. Published: 2019 August 31. 
  38. Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D, et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. 2015 May 22;10(5):e0127672.
  39. Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (Radiofrequency ablation versus Cryoablation) in Atrial flutter patients: A meta-analysis. 2019 May 23;39(5). pii: BSR20182251.
  40. Coffey JO, d’Avila A, Dukkipati S, et al. Catheter ablation of scar-related atypical atrial flutter. 2013;15:414-419. 
  41. Perez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. . 2009 Aug;2(4):393-401. 
  42. Skjøth F, Vadmann H, Hjortshøj SP, et al. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. 2018 Nov;72(11):e13258.
  43. Lin YS, Chen TH, Chi CC, et al. Different implications of heart failure, ischemic stroke, and mortality between nonvalvular atrial fibrillation and atrial flutter — a view from a National Cohort Study. 2017 July 21;6(7). pii: e006406.
  44. Bogossian H, Frommeyer G, Brachmann J. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. 2016 July 1;214:25-30. 
  45. Steinbeck G, Sinner MF, Lutz M, et al. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. 2018 Dec 1;39(45):4020-4029.
  46. Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. . 2019 May 5;25:3316-3320.
  47. De Bortoli A, Shi LB, Ohm OJ, et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. 2017 June;51(3):123-128. 
  48. Chen K, Bai R, Deng W, et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. 2015 July;12(7):1483-1489.
  49. Teh AW, Medi C, Lee G, et al. Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. 2011;34:431-435. 
  50. Expósito V, Rodríguez-Entem F, González-Enríquez S, et al. Stroke and systemic embolism after successful ablation of typical atrial flutter. 2016 June;39(6):347-351. 
  51. Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S. Et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: the PReVENT AF Study I.  2014 Sept;11(9):1567-1572.
  52. Stiles MK, Wong CX, John B, et al. Characterization of atrial remodeling studied remote from episodes of typical atrial flutter. 2010 Aug 15;106(4):528-534. 
  53. Medi C, Teh AW, Roberts-Thomson K, et al. Right atrial remodeling is more advanced in patients with atrial flutter than with atrial fibrillation. 2012 Oct;23(10):1067-1072.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.